Business Insider

New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Quality of Life and Sleep REDWOOD CITY, Calif., Aug. 16, 2023 ...
Seeking Alpha

Nevro: Potentially Better Than Traditional SCS Treatment For Pain And Undervalued

Nevro is a company dedicated to the design and manufacture of medical devices. I believe that further news about the efficacy of the product, sufficient marketing, and internationalization efforts ...
FierceBiotech

Nevro notches high point with CE mark for SCS therapy

Nevro got a CE mark for a new version of its spinal cord stimulation (SCS) therapy for chronic pain. Nevro’s Senza II SCS system is smaller than its original Senza device but provides the same HF10 ...
Seeking Alpha

New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy

Evidence Published in Diabetes Research and Clinical Practice Shows 10 kHz Therapy Yields Lasting Pain Relief and Enhances Health-Related Quality of Life and Sleep Published 24-month data from the ...
Nasdaq

Nevro's (NVRO) New Data Supports SCS Therapy for NSRBP Treatment

Nevro Corp. NVRO recently announced the publication of new 24-month data from the SENZA Nonsurgical Refractory Back Pain (NSRBP) multicenter randomized controlled trial (RCT) in the Journal of ...